201 related articles for article (PubMed ID: 2861078)
1. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
Srikant CB; Heisler S
Endocrinology; 1985 Jul; 117(1):271-8. PubMed ID: 2861078
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-14 and somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3',5'-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells.
Heisler S; Srikant CB
Endocrinology; 1985 Jul; 117(1):217-25. PubMed ID: 2861077
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.
Reisine T
J Pharmacol Exp Ther; 1984 Apr; 229(1):14-20. PubMed ID: 6142943
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
Reisine T; Guild S
J Pharmacol Exp Ther; 1985 Dec; 235(3):551-7. PubMed ID: 2867203
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
Reisine T; Zhang YL; Sekura R
J Pharmacol Exp Ther; 1985 Jan; 232(1):275-82. PubMed ID: 2856941
[TBL] [Abstract][Full Text] [Related]
6. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
7. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
Presky DH; Schonbrunn A
Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors.
Srikant CB; Patel YC
Endocrinology; 1985 May; 116(5):1717-23. PubMed ID: 2859190
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
Litvin Y; Leiser M; Fleischer N; Erlichman J
Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms of somatostatin inhibition of adrenocorticotropin release from mouse anterior pituitary tumor cells.
Reisine T
Endocrinology; 1985 Jun; 116(6):2259-66. PubMed ID: 2859983
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a biotinylated somatostatin analog as a receptor probe.
Schonbrunn A; Lee AB; Brown PJ
Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
[TBL] [Abstract][Full Text] [Related]
13. Prolonged somatostatin pretreatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase.
Reisine T; Axelrod J
Endocrinology; 1983 Aug; 113(2):811-3. PubMed ID: 6135600
[TBL] [Abstract][Full Text] [Related]
14. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
Westendorf JM; Schonbrunn A
Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
[TBL] [Abstract][Full Text] [Related]
15. Forskolin stimulates adenylate cyclase activity, cyclic AMP accumulation, and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
Heisler S; Reisine T
J Neurochem; 1984 Jun; 42(6):1659-66. PubMed ID: 6144727
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C
Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
[TBL] [Abstract][Full Text] [Related]
17. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
Murthy KK; Srikant CB; Patel YC
Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3':5'-monophosphate accumulation in anterior pituitary tumor cells.
Reisine TD; Takahashi JS
J Neurosci; 1984 Mar; 4(3):812-9. PubMed ID: 6142935
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells.
Heisler S; Reisine TD; Hook VY; Axelrod J
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6502-6. PubMed ID: 6128732
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
Heisler S; Desjardins D; Nguyen MH
J Pharmacol Exp Ther; 1985 Jan; 232(1):232-8. PubMed ID: 2981317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
